Tag: Screening
Risk Reduced for Positive NAAT Result With SARS-CoV-2 Antibodies
Patients with positive antibody test initially more likely to have positive NAAT result but less likely after 30 days
FDA: New Variants Mean COVID-19 Vaccines, Tests May Need Tweaking
Agency offers recommendations for companies seeking to modify already-approved vaccines, medicines, and tests so they can remain effective
CRISPR-Based Testing Feasible for SARS-CoV-2 Screening
Study finds technology shows concordance with PCR testing and can detect leading edge of outbreak in asymptomatic people
Drop in PSA Screening Linked to Increase in Metastatic Prostate Cancer
Across states, reductions in PSA screening linked to increased incidence of metastatic prostate cancer at diagnosis
USPSTF Advises Screening for Gestational Diabetes Mellitus
GDM screening recommended at or after, but not before, 24 weeks of gestation in asymptomatic pregnant individuals
SARS-CoV-2 Antibodies Detected Six Months After Infection
12.2 percent of those who reported symptoms or had a positive PCR test sero-reverted within six months of symptom onset
Blood Lead Level Testing Among Children Decreased During COVID-19
Estimated 9,603 children with elevated BLL were missed due to decreased testing in January to May 2020
Patient-Ordered Testing May Up CRC Screening Adherence
Patients self-ordering FIT tests for colorectal cancer screening through an electronic reminder more likely to complete a kit
USPSTF Advises Against Screening for Asymptomatic Carotid Artery Stenosis
USPSTF reaffirms 2014 stance of D recommendation because harms of screening for asymptomatic CAS outweigh the benefits
U.S. Awards Contract for COVID-19 Home Test Kit
With the product from Australian company Ellume, users can swab themselves at home and check their status in about 20 minutes